Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 621-627

  Cho, Byoung Chul ^a,b   Kim, Joo Hang ^a,b   Kim, Choong Bae ^b   Sohn, Ju Hyuk ^a,b   Choi, Hye Jin ^a,b   Lee, Yong Chan ^b   Ahn, Joong Bae ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

5 Fluorouracil; Gastric cancer; Paclitaxel; Palliative chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; PACLITAXEL;

ADULT; AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NEUTROPENIA; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DIARRHEA; DISEASE PROGRESSION; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LEUCOVORIN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCOSITIS; MULTIVARIATE ANALYSIS; NEUTROPENIA; PACLITAXEL; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33645729588     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.621     Document Type: Article

References (26)

1. Wohrer SS, Raderer and Hejna M: Palliative chemotherapy for advanced gastric cancer. Ann Oncol 15: 1585-1595, 2004. (Pubitemid 39567288)
2. Glimelius B, Ekstrom K, Hoffman K, Graf W, Sjoden PO, Haglund U, Svensson C, Enander LK, Linne T, Sellstrom H and Heuman R: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8: 163-168, 1997. (Pubitemid 27112884)
3. Pyrhonen S, Kuitunen T, Nyandoto P and Kouri M: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71: 587-591, 1995.
4. Wils JA, Klein HO, Wagener DJ, et al: Sequential high-dose methotrexate and fluorouracil combined with doxorubicin-a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. J Clin Oncol 9: 827-831, 1991.
5. Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ and Buente H: Phase II study with the combination etoposide, doxorubicin and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7: 1310-1317, 1989. (Pubitemid 19220134)
6. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B and Wils JA: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18: 2648-2657, 2000.
7. Kelsen D, Atiq OT, Saltz L, Niedzwiecki D, Ginn D, Chapman D, Heelan R, Lightdale C, Vinciguerra V and Brennan M: FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 10: 541-548, 1992.
8. Waters JS, Norman A, Cunningham D, et al: Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer 80: 269-272, 1999. (Pubitemid 29210117)
9. Rowinsky EK, Cazenave LA and Donehover RC: Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990. (Pubitemid 20239995)
10. Chang YF, Li LL, Wu CW, Liu TY, Lui WY, P'eng FK and Chi CW: Paclitaxel-induced apoptosis in human gastric carcinoma cell lines. Cancer 77: 14-18, 1996. (Pubitemid 26002731)
11. Ajani JA, Fairweather J, Dumas P, Patt YZ, Pazdur R and Mansfield PF: Phase II study of taxol in patients with advanced gastric carcinoma. Cancer J Sci Am 4: 269-274, 1998.
12. Cascinu S, Graziano F, Cardarelli N, Marcellini M, Giordani P, Menichetti ET and Catalano G: Phase II study of paclitaxel in pretreated advanced gastric cancer. Anticancer Drugs 9: 307-310, 1998. (Pubitemid 28241819)
13. Yamaguchi K, Tada M, Horikoshi N, Otani T, Takiuchi H, Saitoh S, Kanamaru R, Kasai Y, Koizumi W, Sakata Y and Taguchi T: Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer. Gastric Cancer 5: 90-95, 2002. (Pubitemid 34832243)
14. Kim YH, Shin SW, Kim BS, Kim JH, Kim JG, Mok YJ, Kim CS, Rhyu HS, Hyun JH and Kim JS: Paclitaxel, 5-fluorouracil and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma. Cancer 15: 295-301, 1999. (Pubitemid 29051282)
15. Kollmannsberger C, Quietzsch D, Haag C, Lingenfelser T, Schroeder M, Hartmann JT, Baronius W, Hempel V, Clemens M, Kanz L and Bokemeyer C: A phase II study of paclitaxel, weekly, 24-h continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer. Br J Cancer 83: 458-462, 2000. (Pubitemid 30487857)
16. Honecker F, Kollmannsberger C, Quietzsch D, Haag C, Schroeder M, Spott C, Hartmann JT, Baronius W, Hempel V, Kanz L and Bokemeyer C: Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer. Anticancer Drugs 13: 497-503, 2002. (Pubitemid 34624633)
17. Lokich JJ, Sonneborn H, Anderson NR, Bern MM, Coco FV, Dow E and Oliynyk P: Combined paclitaxel, cisplatin and etoposide for patients with previously untreated esophageal and gastroesophageal carcinomas. Cancer 85: 2347-2351, 1999. (Pubitemid 29244842)
18. Murad AM, Petroianu A, Guimaraes RC, Aragao BC, Cabral LO and Scalabrini-Neto AO: Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel, safe and effective regimen. Am J Clin Oncol 22: 580-586, 1999. (Pubitemid 30266056)
19. Bokemeyer C, Hartmann JT, Lampe CS, Clemens MR, Quietzsch D, Forkmann L and Kanz L: Paclitaxel and weekly 24-h infusion of 5-fluorouracil/folinic acid in advanced gastric cancer. Semin Oncol 24 (suppl. 19): 96-100, 1997.
20. Arbuck SG, Douglass HO Jr, Trave F, Milliron S, Baroni M, Nava H, Emrich LJ and Rustum YM: A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma. J Clin Oncol 5: 1150-1156, 1987. (Pubitemid 18045299)
21. Klaassen U, Wilke H and Seeber S: Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer. Semin Oncol 23: 32-37, 1996. (Pubitemid 26362183)
22. Schnirer II, Komaki R, Yao JC, Swisher S, Putnam J, Pisters PW, Roth JA and Ajani JA: Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction. Am J Clin Oncol 24: 91-95, 2001. (Pubitemid 32178680)
23. Constenla M, Garcia-Arroyo R, Lorenzo I, Carrete N, Campos B and Palacios P: Docetaxel, 5-fluorouracil and leucovorin as treatment for advanced gastric cancer: results of a phase II study. Gastric Cancer 5: 142-147, 2002. (Pubitemid 35238893)
24. Kano Y, Akutsu M, Tsunoda S, Ando J, Matsui J, Suzuki K, Ikeda T, Inoue Y and Adachi K: Schedule-dependent interaction between paclitaxel and 5-fluorouracil in human carcinoma cell lines in vitro. Br J Cancer 74: 704-710, 1996. (Pubitemid 26300760)
25. Hallissey MT, Allum WH, Roginski C and Fielding JW: Palliative surgery for gastric cancer. Cancer 62: 440-444, 1988.
26. Doglietto GB, Pacelli F, Caprino P, Alfieri S, Carriero C, Malerba M and Crucitti F: Palliative surgery for far-advanced gastric cancer: a retrospective study on 305 consecutive patients. Am Surg 65: 352-355, 1999. (Pubitemid 29155959)